04/02/2026

MeluXina: Machine Learning for Biomedical Sciences – Accelerating Drug Discovery with ML on HPC

The Luxembourg SuperComputing Competence Center is hosting a webinar 4 February 2026.

Who should attend?

High Performance Computing (HPC) is indispensable in many scientific domains, including biomedical sciences and drug discovery. Over the past decade, computational techniques used in drug discovery have been complemented by machine learning (ML). Combined with GPU acceleration on HPC, ML advanced and accelerated scientific computations in drug discovery. In this workshop, we will explore how ML and HPC can be integrated to enhance computational methodologies in biomedical research.

Target audience

This workshop is designed for anyone who would like to explore and understand how advanced technology shapes the future of biomed research.

GPU Compute Resources  

During the training, participants will have access to the MeluXina supercomputer. For more information about MeluXina, please refer to the MeluXina Overview and the MeluXina – Getting Started Guide. Communication will take place via MicrosoftTeams and email. All training content will be provided in advance on GitHub.

Agenda
This one-day course will be hosted online in Central European Time (CET) on February 4, 2026 (09:00 AM – 05:00 PM).

Important: Limited spots available (25 participants max)!
Registration will close a week before the training date, on the 28 January 2026. 

Contact person for more information: Aleksandra RANCIC – aleksandra.rancic[at]uni.lu



04/02/2026